- Antimicrobial Peptide LL‑37 Contributes to Thrombotic Complications in Patients With COVID‑19 Hematology Advisor
- Early-phase clinical trials in a pandemic: learning from the response to COVID-19 The Lancet
- The severity of COVID-19 compared to seasonal influenza News-Medical.Net
- Use of pragmatic and explanatory trial designs in acute care research: lessons from COVID-19 The Lancet
- Risk of severe COVID-19 in adults with immune-mediated inflammatory diseases and those on immune-modifying therapies News-Medical.Net
- View Full coverage on Google News
Antimicrobial Peptide LL‑37 Contributes to Thrombotic Complications in Patients With COVID‑19 – Hematology Advisor
ByGoogle News
Jun 15, 2022